Bristol-Myers Squibb Co 2025 SR

The report outlines Bristol Myers Squibb's sustainability and social impact progress in 2025. Key highlights include reaching approximately 14.1 million patients globally and expanding access in low- and middle-income countries through the ASPIRE program, reaching 139,700 patients in 2025. The company achieved its goals of training over one million healthcare providers and reaching over 30 million people through health equity initiatives. Additionally, the company integrated AI-native learning systems, MyGrowth and MyLearning, and expanded its peer-based mental health support network to 500 trained allies.

Company: Bristol-Myers Squibb Co

Sector: Health Care

Country: United States

Year: 2025

Type: SR

Pages: 115

Back to company

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co 2025 Impact Report

Impact Report

The report outlines Bristol Myers Squibb's sustainability and social impact progress in 2025. Key highlights include reaching approximately 14.1 million patients globally and expanding access in low- and middle-income countries through the ASPIRE program, reaching 139,700 patients in 2025. The company achieved its goals of training over one million healthcare providers and reaching over 30 million people through health equity initiatives. Additionally, the company integrated AI-native learning systems, MyGrowth and MyLearning, and expanded its peer-based mental health support network to 500 trained allies.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2025

Reporting Period

Jan 1, 2025 - Dec 31, 2025

Fiscal Year

2025

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Women on Board

Workplace Fatalities

Net Zero Target

Employees